Genor Biopharma Holdings Limited (HKG:6998)
Hong Kong
· Delayed Price · Currency is HKD 2.540
0.00 (0.00%)
Jun 6, 2025, 4:08 PM HKT
Genor Biopharma Holdings Revenue
In the year 2024, Genor Biopharma Holdings had annual revenue of 206.23M CNY. Genor Biopharma Holdings had revenue of 191.76M in the half year ending December 31, 2024, with 1,377.80% growth.
Revenue
206.23M CNY
Revenue Growth
n/a
P/S Ratio
6.03
Revenue / Employee
8.59M CNY
Employees
24
Market Cap
1.32B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.53B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| Innovent Biologics | 10.03B |
| WuXi Biologics | 19.87B |
| CSPC Pharmaceutical Group | 28.99B |
| Sino Biopharmaceutical | 30.72B |
| Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |